Ningbo Menovo Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002Y25
CNY
29.44
1.6 (5.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
439.46
400.85
276.48
423.78
341.20
345.11
262.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
439.46
400.85
276.48
423.78
341.20
345.11
262.77
Raw Material Cost
290.67
276.33
198.06
287.39
226.86
269.96
176.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.14
18.64
10.35
27.58
5.25
8.25
7.20
Selling and Distribution Expenses
55.93
58.21
34.25
58.97
49.74
47.83
42.60
Other Expenses
1.40
0.41
0.23
0.51
1.43
1.58
0.61
Total Expenditure (Excl Depreciation)
370.79
357.26
244.93
379.01
296.18
341.84
232.49
Operating Profit (PBDIT) excl Other Income
68.7
43.6
31.6
44.800000000000004
45
3.3000000000000003
30.299999999999997
Other Income
4.84
12.91
10.71
18.93
17.81
-4.24
-3.95
Operating Profit (PBDIT)
64.03
87.58
73.13
71.44
96.01
25.54
51.01
Interest
10.14
18.64
10.35
27.58
5.25
8.25
7.20
Exceptional Items
3.39
-4.82
1.46
3.57
0.13
14.54
6.01
Gross Profit (PBDT)
148.79
124.52
78.43
136.39
114.34
75.15
86.21
Depreciation
0.00
35.36
35.36
38.96
38.96
29.41
29.41
Profit Before Tax
57.27
28.77
28.88
8.48
51.93
2.43
20.42
Tax
9.83
1.52
5.69
-3.87
8.23
1.90
4.65
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
46.87
27.83
21.22
3.56
44.31
4.90
14.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
46.87
27.83
21.22
3.56
44.31
4.90
14.04
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.18
2.06
1.97
4.78
2.17
0.56
1.73
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
48.05
29.90
23.19
8.34
46.48
5.46
15.77
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,314.74
2,245.80
2,219.26
2,192.74
2,171.10
2,115.87
2,110.74
Earnings per share (EPS)
0.2
0.1
0.1
0.02
0.21
0.01
0.07
Diluted Earnings per share
0.2
0.1
0.1
0.02
0.21
0.01
0.07
Operating Profit Margin (Excl OI)
13.47%
9.81%
9.79%
3.2%
11.5%
0.11%
9.72%
Gross Profit Margin
13.03%
16.0%
23.24%
11.19%
26.64%
9.22%
18.96%
PAT Margin
10.67%
6.94%
7.68%
0.84%
12.99%
1.42%
5.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 9.66% vs 44.95% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 60.87% vs 28.88% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -20.75% vs 19.71% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -45.70% vs 78.85% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Ningbo Menovo Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
439.46
0
439.46
Other Operating Income
0.00
0.00
0.00
Total Operating income
439.46
0
439.46
Raw Material Cost
290.67
0
290.67
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.14
0
10.14
Selling and Distribution Expenses
55.93
0
55.93
Other Expenses
1.40
0.00
1.40
Total Expenditure (Excl Depreciation)
370.79
0
370.79
Operating Profit (PBDIT) excl Other Income
68.68
0.00
68.68
Other Income
4.84
0
4.84
Operating Profit (PBDIT)
64.03
0
64.03
Interest
10.14
0
10.14
Exceptional Items
3.39
0
3.39
Gross Profit (PBDT)
148.79
0
148.79
Depreciation
0.00
0
0.00
Profit Before Tax
57.27
0
57.27
Tax
9.83
0
9.83
Provisions and contingencies
0
0
0.00
Profit After Tax
46.87
0
46.87
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
46.87
0
46.87
Share in Profit of Associates
0
0
0.00
Minority Interest
1.18
0
1.18
Other related items
0.00
0.00
0.00
Consolidated Net Profit
48.05
0
48.05
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,314.74
0
2,314.74
Earnings per share (EPS)
0.20
0
0.20
Diluted Earnings per share
0.20
0
0.20
Operating Profit Margin (Excl OI)
13.47%
0%
0.00
13.47%
Gross Profit Margin
13.03%
0%
0.00
13.03%
PAT Margin
10.67%
0%
0.00
10.67%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 43.95 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 9.66% vs 44.95% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 28.81% vs -1.47% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.81 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 60.87% vs 28.88% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 3.44% vs 82.35% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.92 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -20.75% vs 19.71% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -24.30% vs 31.65% in Sep 2024

Quarterly - Interest
Interest 1.01 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -45.70% vs 78.85% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 90.57% vs -23.19% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.47%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024